| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.964 | 0.004 | 0.964 | Analgesic | 0.96 0.004 CID_18804 | ||
| 0.853 | 0.004 | 0.853 | Hypoglycemic | 0.823 0.004 CID_18804 | ||
| 0.775 | 0.005 | 0.775 | HERG channel blocker | 0.721 0.005 CID_18804 | ||
| 0.761 | 0.005 | 0.761 | Potassium channel (Voltage-sensitive) blocker | 0.726 0.005 CID_18804 | ||
| 0.706 | 0.003 | 0.706 | Analgesic, opioid | 0.646 0.003 CID_18804 | ||
| 0.713 | 0.029 | 0.713 | Antiinflammatory | 0.69 0.033 CID_18804 | ||
| 0.622 | 0.011 | 0.622 | Spasmolytic | 0.471 0.027 CID_18804 | ||
| 0.613 | 0.005 | 0.613 | Potassium channel blocker | 0.552 0.008 CID_18804 | ||
| 0.467 | 0.005 | 0.467 | Cholinergic antagonist | 0.353 0.01 CID_18804 | ||
| 0.507 | 0.048 | 0.511 | Cyclophilin D inhibitor | 0.511 0.047 CID_18804 | CID_18804 | |
| 0.437 | 0.006 | 0.437 | Acetylcholine antagonist | 0.327 0.012 CID_18804 | ||
| 0.395 | 0.017 | 0.395 | Anesthetic general | 0.3 0.033 CID_18804 | ||
| 0.372 | 0.008 | 0.372 | Anesthetic local | 0.309 0.012 CID_18804 | ||
| 0.365 | 0.005 | 0.365 | Acetylcholine nicotinic antagonist | 0.327 0.006 CID_18804 | ||
| 0.357 | 0.014 | 0.368 | Tyrosine 3 hydroxylase inhibitor | 0.368 0.012 CID_18804 | CID_18804 | |
| 0.357 | 0.03 | 0.38 | Psychostimulant | 0.38 0.026 CID_18804 | CID_18804 | |
| 0.302 | 0.004 | 0.302 | Opioid mu receptor agonist | 0.223 0.005 CID_18804 | ||
| 0.358 | 0.061 | 0.358 | Cholesterol antagonist | 0.313 0.083 CID_18804 | ||
| 0.334 | 0.063 | 0.334 | Vasodilator, coronary | 0.255 0.13 CID_18804 | ||
| 0.343 | 0.077 | 0.343 | Vasodilator, peripheral | 0.25 0.127 CID_18804 | ||
| 0.316 | 0.065 | 0.573 | 5 Hydroxytryptamine release stimulant | 0.573 0.017 CID_18804 | CID_18804 | |
| 0.279 | 0.037 | 0.29 | Growth hormone agonist | 0.29 0.034 CID_18804 | CID_18804 | |
| 0.234 | 0.005 | 0.234 | Opioid agonist | 0.174 0.006 CID_18804 | ||
| 0.264 | 0.068 | 0.268 | 5 Hydroxytryptamine uptake stimulant | 0.268 0.065 CID_18804 | CID_18804 | |
| 0.26 | 0.079 | 0.26 | Aldehyde oxidase inhibitor | |||
| 0.207 | 0.027 | 0.207 | Arachidonic acid antagonist | 0.194 0.039 CID_18804 | ||
| 0.193 | 0.017 | 0.233 | Adenylate cyclase stimulant | 0.233 0.005 CID_18804 | CID_18804 | |
| 0.165 | 0.003 | 0.165 | Estrogen-related receptor beta agonist | 0.127 0.007 CID_18804 | ||
| 0.264 | 0.114 | 0.264 | Apoptosis antagonist | 0.249 0.129 CID_18804 | ||
| 0.158 | 0.02 | 0.158 | Calcium antagonist | 0.082 0.062 CID_18804 | ||
| 0.147 | 0.013 | 0.152 | Neuronal nicotinic receptor antagonist | 0.152 0.012 CID_18804 | CID_18804 | |
| 0.154 | 0.021 | 0.154 | Prolactin inhibitor | 0.103 0.052 CID_18804 | ||
| 0.152 | 0.024 | 0.152 | Sphingomyelinase inhibitor | 0.114 0.046 CID_18804 | ||
| 0.194 | 0.068 | 0.194 | P-glycoprotein inhibitor | 0.167 0.094 CID_18804 | ||
| 0.159 | 0.04 | 0.159 | Cholesterol synthesis inhibitor | 0.123 0.062 CID_18804 | ||
| 0.148 | 0.034 | 0.148 | Nav1.1 sodium channel blocker | 0.127 0.044 CID_18804 | ||
| 0.139 | 0.038 | 0.139 | Photosensitizer | 0.099 0.092 CID_18804 | ||
| 0.22 | 0.119 | 0.242 | Gastrin inhibitor | 0.242 0.089 CID_18804 | CID_18804 | |
| 0.144 | 0.044 | 0.19 | Vanilloid 1 agonist | 0.19 0.015 CID_18804 | CID_18804 | |
| 0.145 | 0.047 | 0.145 | Acetylcholine muscarinic antagonist | |||
| 0.121 | 0.033 | 0.137 | Catalase inhibitor | 0.137 0.029 CID_18804 | CID_18804 | |
| 0.244 | 0.16 | 0.244 | Histamine release inhibitor | |||
| 0.179 | 0.096 | 0.179 | Insulin sensitizer | 0.162 0.117 CID_18804 | ||
| 0.197 | 0.124 | 0.197 | Neuropeptide Y2 antagonist | |||
| 0.149 | 0.078 | 0.157 | Diuretic | 0.157 0.071 CID_18804 | CID_18804 | |
| 0.141 | 0.071 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.132 0.111 CID_18804 | ||
| 0.125 | 0.055 | 0.125 | Microtubule formation inhibitor | 0.115 0.067 CID_18804 | ||
| 0.225 | 0.156 | 0.248 | Sodium/bile acid cotransporter inhibitor | 0.248 0.13 CID_18804 | CID_18804 | |
| 0.16 | 0.092 | 0.16 | Lipocortins synthesis antagonist | 0.147 0.109 CID_18804 | ||
| 0.178 | 0.111 | 0.18 | 5 Hydroxytryptamine 3E antagonist | 0.18 0.107 CID_18804 | CID_18804 | |
| 0.119 | 0.053 | 0.12 | Aminopeptidase B inhibitor | 0.12 0.053 CID_18804 | CID_18804 | |
| 0.173 | 0.107 | 0.194 | Neurotrophic factor enhancer | 0.194 0.082 CID_18804 | CID_18804 | |
| 0.074 | 0.014 | 0.076 | Acetyl-CoA transferase 2 inhibitor | 0.076 0.013 CID_18804 | CID_18804 | |
| 0.114 | 0.058 | 0.114 | Falcipain 3 inhibitor | |||
| 0.158 | 0.102 | 0.158 | Hepatoprotectant | 0.158 0.101 CID_18804 | ||
| 0.135 | 0.08 | 0.168 | Protein kinase stimulant | 0.168 0.057 CID_18804 | CID_18804 | |
| 0.071 | 0.021 | 0.072 | Lipocortins synthesis agonist | 0.072 0.019 CID_18804 | CID_18804 | |
| 0.063 | 0.015 | 0.063 | Liver X receptor agonist | 0.052 0.021 CID_18804 | ||
| 0.121 | 0.076 | 0.121 | Cyclooxygenase 3 inhibitor | 0.119 0.078 CID_18804 | ||
| 0.104 | 0.06 | 0.104 | Gastric antisecretory | 0.093 0.074 CID_18804 | ||
| 0.083 | 0.04 | 0.086 | Aminopeptidase I inhibitor | 0.086 0.037 CID_18804 | CID_18804 | |
| 0.102 | 0.06 | 0.102 | Anabolic | 0.087 0.083 CID_18804 | ||
| 0.107 | 0.068 | 0.107 | Mucolytic | 0.094 0.086 CID_18804 | ||
| 0.084 | 0.046 | 0.084 | Interferon agonist | |||
| 0.148 | 0.11 | 0.148 | Phospholipase C inhibitor | |||
| 0.07 | 0.037 | 0.078 | Protease 3C (Human rhinovirus) inhibitor | 0.078 0.029 CID_18804 | CID_18804 | |
| 0.174 | 0.143 | 0.181 | Calpain inhibitor | 0.181 0.134 CID_18804 | CID_18804 | |
| 0.067 | 0.037 | 0.135 | Adrenaline uptake inhibitor | 0.135 0.011 CID_18804 | CID_18804 | |
| 0.042 | 0.013 | 0.042 | Liver X receptor antagonist | 0.036 0.016 CID_18804 | ||
| 0.047 | 0.018 | 0.047 | GABA uptake inhibitor | |||
| 0.146 | 0.12 | 0.146 | Succinate dehydrogenase inhibitor | 0.14 0.132 CID_18804 | ||
| 0.121 | 0.095 | 0.121 | Nav1.6 sodium channel blocker | |||
| 0.115 | 0.09 | 0.115 | Nav1.2 sodium channel blocker | 0.105 0.104 CID_18804 | ||
| 0.251 | 0.227 | 0.256 | 5 Hydroxytryptamine release inhibitor | 0.256 0.22 CID_18804 | CID_18804 | |
| 0.05 | 0.026 | 0.05 | Benzodiazepine antagonist | |||
| 0.165 | 0.142 | 0.165 | Immunostimulant | |||
| 0.035 | 0.012 | 0.035 | Urotensin II agonist | |||
| 0.031 | 0.009 | 0.031 | Vanilloid 2 agonist | 0.031 0.009 CID_18804 | ||
| 0.103 | 0.083 | 0.103 | DNA polymerase I inhibitor | |||
| 0.084 | 0.064 | 0.084 | Opioid antagonist | 0.082 0.066 CID_18804 | ||
| 0.024 | 0.006 | 0.024 | Estrogen-related receptor gamma agonist | 0.023 0.007 CID_18804 | ||
| 0.072 | 0.054 | 0.083 | Glutamate dehydrogenase inhibitor | 0.083 0.042 CID_18804 | CID_18804 | |
| 0.036 | 0.019 | 0.036 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.09 | 0.072 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.062 CID_18804 | CID_18804 | |
| 0.197 | 0.18 | 0.197 | Antithrombotic | 0.194 0.185 CID_18804 | ||
| 0.073 | 0.056 | 0.073 | GABA aminotransferase inhibitor | |||
| 0.053 | 0.04 | 0.053 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.049 | 0.036 | 0.049 | Squalene epoxidase inhibitor | |||
| 0.03 | 0.019 | 0.03 | Liver X receptor alpha antagonist | 0.027 0.025 CID_18804 | ||
| 0.099 | 0.089 | 0.099 | Alkylator | |||
| 0.024 | 0.013 | 0.026 | Bombesin agonist | 0.026 0.011 CID_18804 | CID_18804 | |
| 0.164 | 0.154 | 0.191 | Interleukin agonist | 0.191 0.129 CID_18804 | CID_18804 | |
| 0.061 | 0.052 | 0.061 | Interferon inducer | |||
| 0.123 | 0.116 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.199 | 0.192 | 0.211 | Interleukin 2 agonist | 0.211 0.171 CID_18804 | CID_18804 | |
| 0.03 | 0.023 | 0.03 | Squalene synthetase inhibitor | |||
| 0.043 | 0.037 | 0.044 | Adenylate cyclase 1 inhibitor | 0.044 0.034 CID_18804 | CID_18804 | |
| 0.019 | 0.013 | 0.02 | Bombesin 3 receptor agonist | 0.02 0.011 CID_18804 | CID_18804 | |
| 0.117 | 0.113 | 0.117 | Acetylcholine M1 receptor antagonist | |||
| 0.1 | 0.097 | 0.1 | Nav1.3 sodium channel blocker | |||
| 0.033 | 0.032 | 0.033 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.069 | 0.069 | 0.073 | Vanilloid 4 agonist | 0.073 0.056 CID_18804 | CID_18804 | |
| 0.135 | 0.144 | 0.148 | Neurotensin receptor agonist | 0.148 0.105 CID_18804 | CID_18804 | |
| 0.022 | 0.032 | 0.025 | Acid ceramidase inhibitor | 0.025 0.019 CID_18804 | CID_18804 | |
| 0.177 | 0.195 | 0.197 | Insulysin inhibitor | 0.197 0.162 CID_18804 | CID_18804 | |
| 0.036 | 0.054 | 0.044 | Histamine H1 receptor agonist | 0.044 0.03 CID_18804 | CID_18804 | |
| 0.109 | 0.129 | 0.114 | Sphingosine 1-phosphate receptor 2 antagonist | 0.114 0.113 CID_18804 | CID_18804 | |
| 0.063 | 0.087 | 0.098 | Ornithine decarboxylase inhibitor | 0.098 0.046 CID_18804 | CID_18804 | |
| 0.018 | 0.047 | 0.04 | Renin inhibitor | 0.04 0.023 CID_18804 | CID_18804 | |
| 0.041 | 0.07 | 0.082 | Factor III inhibitor | 0.082 0.007 CID_18804 | CID_18804 | |
| 0.17 | 0.202 | 0.195 | Transcription factor NF kappa B inhibitor | 0.195 0.174 CID_18804 | CID_18804 | |
| 0.047 | 0.083 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.056 0.036 CID_18804 | CID_18804 | |
| 0.069 | 0.114 | 0.106 | Vanilloid agonist | 0.106 0.027 CID_18804 | CID_18804 | |
| 0.076 | 0.125 | 0.107 | Proteasome inhibitor | 0.107 0.079 CID_18804 | CID_18804 | |
| 0.118 | 0.176 | 0.153 | ATPase inhibitor | 0.153 0.096 CID_18804 | CID_18804 | |
| 0.037 | 0.1 | 0.062 | Bombesin 1 receptor agonist | 0.062 0.038 CID_18804 | CID_18804 | |
| 0.141 | 0.22 | 0.224 | Peptidyltransferase inhibitor | 0.224 0.073 CID_18804 | CID_18804 | |
| 0.032 | 0.117 | 0.059 | Carbonic anhydrase stimulant | 0.059 0.042 CID_18804 | CID_18804 | |
| 0.153 | 0.239 | 0.222 | Calpain 2 inhibitor | 0.222 0.169 CID_18804 | CID_18804 | |
| 0.19 | 0.291 | 0.512 | Calcium channel L-type activator | 0.512 0.024 CID_18804 | CID_18804 | |
| 0.039 | 0.432 | 0.123 | Toll-Like receptor 3 antagonist | 0.123 0.027 CID_18804 | CID_18804 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |